๐ฌ Current Disease Focus:
Task Progress: 0%
๐ฅ Active Problem Solvers
0
๐ Experts collaborating globally
โก Current Task Assignment
๐งฌ Genetic Analysis
๐ Matching experts to specific tasks
๐ Resource Allocation by Research Phase:
๐ Data Analysis
๐งช Experimental Design
๐ฌ Clinical Trials
๐ Treatment Development
The diagnosis of abuse in children relies heavily on the presence of skelet...
Status
Completed
Location
CHU Rennes
Start Date
2011-08-01
Trial ID
NCT01743703
Treatments Being Tested
Bone disease in multiple myeloma (MM) is routinely assessed by skeletal X-r...
Status
Completed
Location
Multiple Locations
Start Date
2008-07
Trial ID
NCT01829412
Treatments Being Tested
Background: GM1 gangliosidosis is a disorder that destroys nerve cells. It...
Status
Recruiting
Location
National Institutes of Health Clinical Center
Start Date
2019-08-19
Trial ID
NCT03952637
Treatments Being Tested
This phase II trial compares iberdomide maintenance therapy to disease moni...
Status
Suspended
Location
UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care
Start Date
2024-08-27
Trial ID
NCT06179888
Investigators are recruiting adults (men and women, ages 18 to 65 years, in...
Status
Completed
Location
University of Pennsylvania
Start Date
2017-02-14
Trial ID
NCT02920671
This phase II trial studies the effect of isatuximab, carfilzomib, pomalido...
Status
Active Not Recruiting
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2021-07-29
Trial ID
NCT04883242
Osteogenesis Imperfecta (OI) is a rare disorder that causes bones to break ...
Status
Completed
Location
Oregon Health Science University
Start Date
2017-11-15
Trial ID
NCT03064074
Treatments Being Tested
This phase I trial will evaluate the safety, side effects, and best dose of...
Status
Recruiting
Location
University of Calfornia, San Francisco
Start Date
2025-07-28
Trial ID
NCT06348108
Treatments Being Tested
The primary objective of this 2-year pilot project is to test the hypothesi...
Status
Completed
Location
Washington University School of Medicine
Start Date
2006-03
Trial ID
NCT00603967
Treatments Being Tested
This phase I/II trial studies the best dose and effect of belantamab mafodo...
Status
Terminated
Location
Mayo Clinic in Rochester
Start Date
2021-06-03
Trial ID
NCT04892264